找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Surgical Oncology Manual; Frances C. Wright,Jaime Escallon,Usmaan Hameed Book 20162nd edition University of Toronto General Surgery Oncolo

[復(fù)制鏈接]
樓主: 雜技演員
21#
發(fā)表于 2025-3-25 04:13:57 | 只看該作者
22#
發(fā)表于 2025-3-25 10:41:13 | 只看該作者
Jennifer Racz M.D., M.B.A., F.R.C.S.C.,Anthony M. Joshua M.B.B.S., Ph.D., F.R.A.C.P.,Joan E. Lipa MD
23#
發(fā)表于 2025-3-25 14:18:11 | 只看該作者
Trevor D. Hamilton M.D., F.R.C.S.C.,Savtaj S. Brar M.D., M.Sc., F.R.C.S.C,Nicole J. Look Hong M.D.,
24#
發(fā)表于 2025-3-25 17:31:45 | 只看該作者
25#
發(fā)表于 2025-3-25 21:13:46 | 只看該作者
Tumours of the Adrenal Gland,surgical resection and consideration of adjuvant mitotane. Pheochromocytomas may be benign or malignant. Essential components of perioperative management include alpha blockage followed by beta blockade.
26#
發(fā)表于 2025-3-26 04:06:32 | 只看該作者
Gastric Adenocarcinoma,iotherapy plays an important role in both the adjuvant and palliative setting. The complex multidisciplinary management of gastric cancer remains in evolution as we strive to further improve outcomes in this patient population.
27#
發(fā)表于 2025-3-26 07:38:17 | 只看該作者
Melanoma,esection, intralesional agents, topical therapy, and limb infusion/perfusion. Systemic therapies for distant metastatic melanoma have dramatically improved in the past decade with the use of targeted BRAF and MEK inhibitors, immunotherapy with anti-CTLA4 agents and PD-1 inhibitors.
28#
發(fā)表于 2025-3-26 10:51:44 | 只看該作者
Adenocarcinoma of the Pancreas,Treatment of pancreatic cancer depends on the stage of disease. Surgery is the only curative treatment for localized disease. Completeness of resection (R0) is prognostically important. Adjuvant chemotherapy is currently recommended as standard of care.
29#
發(fā)表于 2025-3-26 15:33:06 | 只看該作者
Breast Cancer,g of the complete spectrum of breast pathology, both malignant and premalignant. Within this chapter, an overview of this continuum is presented: from high-risk pathologies, through pre-invasive disease, to invasive disease and its subtypes. Relevant trials are presented, as are options and considerations for breast reconstruction.
30#
發(fā)表于 2025-3-26 20:15:55 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-20 19:34
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
广平县| 潜江市| 镇宁| 卓资县| 沙洋县| 邵东县| 迁安市| 临泉县| 崇仁县| 宜章县| 平乐县| 祁门县| 怀远县| 邢台市| 邵阳市| 伊宁市| 青神县| 郴州市| 家居| 乌拉特前旗| 呼和浩特市| 卢龙县| 华容县| 平利县| 津南区| 当阳市| 金阳县| 揭东县| 邳州市| 永新县| 鹿邑县| 河源市| 方城县| 体育| 武隆县| 封丘县| 辽阳市| 商水县| 汝阳县| 洱源县| 株洲市|